Based on previous findings, IRF5 has multiple TSSs dedicated to distinct alternative promoters and IRF5 isoforms (Supplementary Fig. 5a) that differ in their ability to transactivate the IFN genes47 and modulate autoimmune disease risk24,27,48. The gene discussed is IRF5; the disease is autoimmune disease.